Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Jentadueto XR vs Free Combination of Linagliptin and Metformin ER
NCT02084082Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of linagliptin and liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by Boehringer Ingelheim. Started Apr 2014; status: completed.
02
Drugs
linagliptinliquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02084082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02084082.